Science ❯ Medical Research

Clinical Trials

Drug Development Drug Efficacy Vaccine Efficacy Patient Outcomes Vaccine Development Vaccine Trials Oncology AI in Medicine Cancer Research Pharmacology Evidence-Based Medicine Gene Therapy Psychedelic Research Pediatric Studies Transplantation Research Pharmaceuticals Epidemiology Phase 3 Studies Vision Restoration Cancer Treatment Transplantation Studies Diabetes Research Drug Safety Placebo-Controlled Trials Ethics in Medicine Therapeutic Development Study Findings Innovative Treatments Efficacy Studies Exercise Impact Food Allergy Treatments LEAP Trial Heart Disease Studies Neurodegenerative Diseases Food Allergy Studies Prostate Cancer Transplant Research Weight Loss Studies Cardiovascular Health Exercise Physiology Pediatric Ophthalmology Adverse Events Infectious Diseases Allergy Studies Innovations in Medicine Animal Studies Immunotherapy Ophthalmology Diabetes Studies Drug Candidates Biomarkers Lifestyle Interventions Gene Therapy Research Neurology Animal Testing Data Analysis Vaccine Safety Alzheimer's Research Cancer Drug Trials Puberty Blockers Patient Involvement Patient Care Obesity Studies Gender-Affirming Treatments Hormonal Treatments Alzheimer's Drug Trials Cannabis Studies Patient Studies Mental Health Studies Therapeutics Ethics in Research Transplantation Trials Epilepsy Research Treatment Efficacy Veterinary Clinical Trials Bacterial Vaginosis Autoimmune Diseases Pharmaceutical Industry Aspirin Research Funding Puberty Blockers Studies Fecal Transplants Antibiotic Resistance Alzheimer's Disease Gender Dysphoria Network Meta-Analysis HIV Studies Biological Markers Antivenom Efficacy Virology Biomarker Research Transgender Youth Studies Antibody Treatments Vaccine Formulations Placebo Testing Accuracy in Testing Cognitive Function Immunogenicity Studies Antiretroviral Drugs Vitamin D Studies

Prime Editing Tool PERT Debuts as Broad, One-Time Strategy for Nonsense Mutations

The method equips cells with a permanent readthrough tRNA, pointing to a one-time therapy paradigm.

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Study Finds NIH Cut Funding to 383 Clinical Trials, Affecting 74,000 Participants

Pig Kidney Survives 61 Days in Human as Scientists Map and Reverse Rejection

Novartis Opens Carlsbad Radioligand Therapy Plant as U.S. Buildout Accelerates

Transatlantic Remote Robotic Thrombectomy Demonstrated on Cadaver

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Beta-Blockers Offer No Benefit After Heart Attack With Preserved Heart Function, Meta-Analysis Finds

Senate Democrats Press FDA on Mifepristone Review After Court Strikes Down Restrictions

AI App Matches Human-Led Diabetes Prevention in Phase 3 Trial

First Human Trial Finds Enteral Ventilation Safe in Healthy Volunteers

Early Peanut-Feeding Guidance Linked to 43% Drop in Childhood Peanut Allergies, U.S. Study Finds

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

FDA Accepts Replimune’s Resubmitted RP1 Melanoma Filing, Sets April 2026 Decision

South Africa Sets April 2026 Rollout for Twice-Yearly HIV-Prevention Shot, With Limited Early Supply

First Therapeutic Pig-to-Human Liver Transplant Works for Weeks in Living Patient

MHRA Reforms and AI Cut UK Clinical Trial Approval Times to 41 Days

FDA Moves to Authorize Leucovorin for Cerebral Folate Deficiency Linked to an Autism Subgroup

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use